HopeStage
Back to all studies
Not Yet RecruitingNCT06341608

Developing and testing telehealth support for buprenorphine treatment

About this titleRead the official source — NCT06341608
Behavioural studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
PhiladelphiaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: September 15, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
60
Sponsor
University of Pennsylvania
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06341608
Official title
Show the full official title

Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention

Recruitment & locations

Not yet recruiting

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pennsylvania, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies